Uncategorized

As multiple companies vie to expand on Alnylam’s success in commercializing RNAi therapeutics, the pioneering company has set a goal of targeting small interfering RNA to any organ by 2030.

The move comes after a recent investigation found Chinese government procurement practices discriminate against EU companies in China’s domestic market.

The health system promoted Lisa Foo, its executive vice president of commercial operations, to the role effective May 30, according to a securities filing.

The Ohio-based health system said it had reason to believe ransomware group Interlock launched the attack in late May. Kettering is still recovering from the incident, which disrupted patient care.

The companies scrapped the merger because securing FTC clearance “proved unviable in terms of time, expense and opportunity.”

The American Public Health Association and dozens of other experts had harsh words for Georgia’s request to continue its controversial “Pathways to Coverage,” saying it enrolls fewer beneficiaries at a higher cost.

The Seattle-based company came to ASCO25 with new data on its neuroendocrine tumor–treating lead therapy, with big vibes and speedy speech.

If the tube moves out of place, it could prevent a patient from breathing or block the airway. A Medtronic spokesperson said patient harm was reported in some cases.

Otsuka’s investigational antibody sibeprenlimab approximately halved levels of this key biomarker in patients with immunoglobulin A nephropathy.

Given the evidence, the committee has recommended that the labels for Novo Nordisk’s Wegovy and Ozempic be updated to include the “very rare” risk of non-arteritic anterior ischemic optic neuropathy.